A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis

Trial Profile

A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Aug 2017

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Proof of concept; Therapeutic Use
  • Acronyms PENNANT
  • Sponsors Mallinckrodt LLC
  • Most Recent Events

    • 14 Jun 2017 According to a Mallinckrodt media release, first patient has been enrolled in this trial.
    • 14 Jun 2017 Status changed from not yet recruiting to recruiting, according to a Mallinckrodt media release.
    • 01 Mar 2017 Status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top